DCT

3:20-cv-03106

Mitsubishi Tanabe Pharma Corp v. Aurobindo Pharma USA Inc

General

Filed

03/20/20

Cause of ActionPatent Infringement

SectorBiotech

Status

Closed (06/01/20)

Patent Owner

Operating Company (W)

PACER

Nature of Suit835 ANDA

Judge	Period	PO Win Rate
Freda L. Wolfson	03/23/20 - 06/03/20	76%

Magistrate

Douglas E. Arpert

Plaintiff

Party

Name	Ratings
Mitsubishi Tanabe Pharma Corp	L4 E
Janssen Research Development LLC	L5 A
Janssen Research & Development LLC	L5 A
Janssen Pharmaceuticals Inc	L5 A
Janssen Pharmaceutica NV	L5 A
Cilag GMBH	L5 A

No Parties

Attorney

Name	Ratings
Quinn Emanuel Urquhart & Sullivan LLP	L5 A
Raymond N. Nimrod	L4 A
Caty Lacey	L4 B
Colleen T. James	-- -- --
Paul Hastings LLP	L4 E
Joseph M. O'Malley	L5 A
Eric W. Dittmann	L3 A
Isaac S. Ashkenazi	L2 A
Dana Weir	L1 C
Max Yusem	L1 C
Saul Ewing LLP	L3 B
William C. Baton	L5 A
Charles M. Lizza	L5 A
Sarah Ann Sullivan	L5 A

No Attorneys

Defendant

Party

Name	Ratings
Aurobindo Pharma USA Inc	L4 E

No Parties

Attorney

Name	Ratings
Cosner & Youngelson	-- -- --
Marc D. Youngelson	-- -- --

No Attorneys